Trichomoniasis

 Trichomoniasis 

Trichomoniasis is an infection of the lower genital trait in men and women and is caused by an anearobic, motile protozoan trichoman vaginalis. It is categorized as a sexually transmitted disease (STD) with its transmission felt to be principally by direct intimate contact.

 

Trichomoniasis vaginalis is significant because of the sever vaginitis and its common association with other sexually transmitted infections, particularly Neisseria gonorrhea and Chlamydia trachomatis.


Risk Factor

 

Studies have indicates that there are multiple risk factors for trichomoniasis

 

Includes

 

·        low socio economic status

 

·        lack of education

 

·        crowded living conditions

 

·        lack of sanitation

 

·        and poor personal hygiene 

 

However, the principal risk factors, which overides all others, is multiple sexual partners, as is true for most other STDs.

 

Signs and Symptoms

 

Trichomoniasis is a leading cause of vulvovaginitis and occasionally cervicitis and cystitis in women. It is a cause of mild urethritis in men, and may rarely cause prostatitis and epididymitis.

In women-pruritis and burning sensation of vagina

 

·        an increase in vaginal discharge which range from normal to copious, grayish in colour and some what bubbly in character.

·        the green, frothy discharge and friable erythematous cervix

·        urethritis

·        Asymptomatic infection may sometimes be detected on a papanicolau smear

·        Dysuria and dysparunia

 

 

Diagnosis

 

·        wet smear examination under a microscope

 

·        Culture

 

·        cytological examination

 

 

Treatment

 

A single oral dose of metronidazole 2 gm or a 5-day course of 400mg twice daily is the treatment of choice. Since metrondiazol is used in first trimester of pregnancy clortrimazole may be used as local treatment.

A women man's partner should also be treated with metrindiazole.(the same as woman dose)

Conventional advice suggests the avoidance of intercourse until treatment is complete.

Comments

  1. Krasimir TodorApril 1, 2022 at 6:32 PM

    I was diagnosed with Liver cancer in August 2020. A valuable friend told me about Dr. Itua Herbal Center in West Africa. She gave me her phone number and email address. I quickly contacted him to guarantee that his herbal medicines will heal my cancer and I will heal forever I said OK.I ask him what is the healing process, he asks me to pay the fees I did and within 7 working days he sent me the herbal medicine and then he asked me I told my friend Gomez about the herbal drug so that he gave me to go and drink it.So after drinking for two weeks, I was cured, I am so grateful and I promise that I will do it I recommend to anyone who has cancer and that that I am doing. Herbal medicine Dr. Itua makes me believe that there is hope for people with Parkinson's disease,Leukemia, Fibromyalgia,Epilepsy,Diabetes, Celiac Disease,Arthritis,Alzheimer's Disease, Lupus, Adrenocortical Carcinoma.Asthma, Allergic Diseases.HIV, Gestational trophoblastic disease,Hodgkin lymphoma,Melanoma,Mesothelioma,Multiple myeloma,Neuroendocrine tumors,Meniere's disease,Herpes,Chronic inflammatory, Memory disorder,
    Here is his contact information ...... [Email ... drituaherbalcenter@gmail.com. Whatsapp ... + 2348149277967]

    ReplyDelete

Post a Comment

Popular posts from this blog

Strategies of drug development

Image
  Strategies of drug development   Drug development strategies may be classified as follows:   1.    Rational design   2.    Brute force   3.    Traditional medicine / natural products   4.    Mere chance.   Note that these distinctions are not really sharp in practice. E.g., the development of H 2 -receptor blockers described above would be a mixture of strategies 1 and 2. In reality, one will always try to rationally make use of as much infor-mation as possible and then play some kind of lottery to do the rest.   An example of the rational approach to drug design is pro-vided by the development of HIV (human immune defi-ciency virus) protease inhibitors. HIV protease cleaves vi-ral polyproteins – the initial products of translation – into the individual protein components and thus is essential for the maturation of virus particles. The crystal structure of HIV protease was used to design synthetic molecules that would snugly fit into the active site. Figure 1.11 shows the inhibitor s
Read more

Magnitude of Maternal Health problem in Ethiopia

  Magnitude of Maternal Health problem in Ethiopia   Maternal mortality is one of the health indicator which shows the burden of disease and death; the greatest differential between developing and developed countries. More than 150 million women become pregnant in developing countries each year and an estimated 500, 000 of them die from pregnancy related causes. Other than their health problems most women in the developing countries lack access to modern health care services and increase the magnitude of death from preventable problems. Lack of access to modern health care services has great impact on increasing maternal death. Most pregnant women do not receive antenatal care; deliver with out the assistance of trained health workers etc. The life time risk of death as a result of pregnancy or child birth is estimated at one in twenty – three for women in Africa, compared to about one in 10,000 for women in Northern Europe 75% of Maternal morbidity and mortality related to pregnancy a
Read more